本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Evofem Biosciences, Inc.

0.0089
0.0000
成交量:8,124.00
成交額:72.30
市值:117.95萬
市盈率:25.00
高:0.0089
開:0.0089
低:0.0089
收:0.0089
52周最高:0.0200
52周最低:0.0069
股本:1.33億
流通股本:1.13億
量比:0.18
換手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):0.0004
每股收益(LYR):0.0004
淨資產收益率:-387.27%
總資產收益率:4.08%
市淨率:-0.02
市盈率(LYR):25.00

資料載入中...

2019/10/11

重要事件披露

Current report, item 1.01
2019/10/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/04

重要事件披露

Current report, items 7.01 and 9.01
2019/08/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/06

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/05

重要事件披露

Current report, items 2.02 and 9.01
2019/07/10

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/01

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/28

SEC問詢函

[Cover]Correspondence
2019/06/12

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/06/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership